| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2015-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02943e1e7b12a5470099611546249e49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a0024d64528c8692972583c50df786b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68d71b819a5a35fa8604e1ec66dabb9 |
| publicationDate |
2016-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3103453-A1 |
| titleOfInvention |
Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient |
| abstract |
[Problem] To provide: a medicinal composition for treating an AXL-related cancer; in another embodiment, a medicinal composition for treating a cancer with high expression of AXL; and, in still another embodiment, a medicinal composition for treating a cancer that has acquired resistance through activation of AXL against anticancer agent therapy. [Solution] As the results of an examination on compounds having AXL inhibitory effect, the present inventors confirmed that specific diamino heterocyclic carboxamide compounds have AXL inhibitory effect and medicinal compositions comprising such a compound as an active ingredient have therapeutic effect on an AXL-related cancer, on a cancer with high expression of AXL in another embodiment, and on a cancer that has acquired resistance through activation of AXL against anticancer agent therapy in still another embodiment, thereby completing the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744134-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3372231-A4 |
| priorityDate |
2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |